期刊文献+

体外诱导Tca8113细胞产生耐药性的分析 被引量:6

Induction of Drug Resistance in Tca8113 Cell Line by Exposing to Chemotherapy Drug
暂未订购
导出
摘要 目的探讨Tca8113细胞长期接触卡铂以后耐药性表达情况。方法以Tca8113细胞系为研究对象,采用间歇性加药,逐步递增剂量,体外连续培养诱导其产生耐药性。用MTT法检测细胞耐药指数,LsAB免疫组化法检测耐药蛋白P糖蛋白-170(Pgp-170)、谷胱苷肽S转移酶-π(GST-π)、多药抗药性相关蛋白(MRP)和拓扑异构酶Ⅱ(TopoⅡ)的表达,RT-PCR检测多药耐药基因(MDR)、MRP和GST-π的表达。结果诱导后Tca8113/卡铂(CBP)对氨甲喋呤(MTX)、CBP、平阳霉素(PYM)、长春新碱(VCR)的抗药性明显升高,但对5-氟尿嘧啶(5-FU)抗药性增加不明显。在免疫组化和RT-PCR中Pgp-170、MRP和GST-π表达升高,TopoⅡ表达降低。结论Tca8113细胞系在卡铂长期刺激的环境中多种耐药相关蛋白表达上升,表明肿瘤细胞的耐药现象受到多种基因的调节。Tca8113/CBP可以作为一个肿瘤耐药研究的平台。 Objective To study the drug resistance changes in Tca8113 cell lines by exposing to carboplatin. Methods The concentration of carboplatin added to Tca8113 ceils was increased gradually and continually, which was to induce the carboplatin-resistance in Tca8113 ceils. The sensibility to drugs of the ceils was analyzed by MTY method. Immunocytochemistry and RT-PCR were utilized to examine the expression of multidrug resistance proteins and genes. Results After exposing to carboplatin, the Tca8113/CBP ceils had higher drug-resistance to CBP, MTX, PYM, VCR and higher expression of MRP, GST-π than Tca8113 ceils. Conclusion Muhidrug resistance of Tca8113/CBP is associated with over expression of MRP, GST-π and MDR. Tca8113/CBP can provide an ideal modal for multidrug resistance research.
出处 《华西口腔医学杂志》 CAS CSCD 北大核心 2007年第2期184-187,共4页 West China Journal of Stomatology
基金 国家自然科学基金资助项目(39970798) 四川大学优秀博士论文研究基金资助项目(0040305505010)
关键词 TEA8113细胞 多药耐药性 卡铂 Tca8113 ceil line multidrug resistance carboplatin
  • 相关文献

参考文献9

  • 1Koshiyama M,Fujii H,Kinezaki M.Immunohistochemical expression of topoisomerase Ⅱ alpha (Topo Ⅱ alpha) and multidrug resistance-associated protein(MRP),plus chemosensitivity testing,as chemotherapeutic indices of ovarian and endometrial carcinomas[J].Anticancer Res,2001,21 (4B):2925-2932.
  • 2Kool M,De Haas M,Scheffer GL.Analysis of expression of cMOAT (MRP2),MRP3,MRP4,and MRP5,homologues of the multidrug resistance-associated protein gene (MRP1),in human cancer cell lines[J].Cancer Res,1997,57(16):3537-3547.
  • 3何嘉,王大章,郑光勇,冯戈.唾液腺粘液表皮样癌组织P-gp单克隆抗体JSB-1及GST-π抗体的检测[J].华西口腔医学杂志,2004,22(2):115-116. 被引量:8
  • 4Chen GK,Dura GE,Mangili A.MDR1 activation is the predominant resistance mechanism selected by vinblastine in MESSA cells[J].Br J Cancer,2000,83 (7):892-898.
  • 5Gozalez VM,Fuertes MA,Alonso C,et al.Is cisplatin-induced cell death always produced by apoptosis[J].Mol Pharmacol,2001,59 (4):657-663.
  • 6Welters MJP,Fichtinger-Schepman H,Bann RA,et al.Role of glutathione,glutathione S-transferases and multidrug resistancerelated protein in cisplatin-resistance of head and neck cancer cell lines[J].Br J Cancer,1998,77 (4):556-561.
  • 7Newkirk K,Heffern J,Scloman-Moll E,et al.Glutathione content but not gamma glutamy 1 cysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cancer cell lines[J].Cancer Chemother Pharmacol,1997,40(1):75-80.
  • 8Brock I,Hiptner DR,Nielsen BS,et al.Sequential coexpression of the multidrug resistance genes MRP and mdr1 and their products in VP-16-selected H69 small cell lung cancer cells[J].Cancer Rea,1995,55(3):459-462.
  • 9张萍,王大章,郑光勇,廖楚航.体外短期化疗诱导Tca8113细胞株产生耐药性的研究[J].华西口腔医学杂志,2003,21(1):70-73. 被引量:7

二级参考文献10

  • 1梁巍.多药耐药基因的结构、功能及其表达调控[J].国外医学(药学分册),1997,24(3):139-143. 被引量:4
  • 2[1]Izquierdo MA, Scheffer GL, Flens MJ, et al. Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. Am J Pathol, 1996, 148(3): 877-887
  • 3[2]Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst, 1993, 85(8):632-639
  • 4[3]Hu XF, Slater A, Wall DM, et al. Rapid up-regulation of mdr1 expression by anthracyclines in a classical multidrug-resistant cell line. Br J Cancer, 1995, 71(5): 931-936
  • 5[4]Abbaszadegan MR, Futscher BW, Klimecki WT, et al. Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res, 1994, 54(17): 4676-4679
  • 6Mulder TJP.Glutathione S-transferase and glutathione in human head and n eck cancer[J].Carcinogenesis,1995,16(5):619.
  • 7Uematsu T,Hasegawa T,Hiraoka BY,et al.Multidrug resistance gene 1 exp ression in salivary gland adenocarcinomas and oral squamous-cell carcinomas[J] .Int J Cancer,2001,92(2):187-194.
  • 8Kelley DJ,Pavelic ZP,Gapany M,et al.Detection of P-glycoprotein in sq uamous cell carcinomas of head and neck[J].Arch Otolaryngol Head Neck Surg,1993,119(3):411-414.
  • 9张建国,刘浩,章魁华,刘昕燕,高岩.谷胱苷肽S转移酶在涎腺肿瘤中的表达[J].现代口腔医学杂志,1997,11(2):84-86. 被引量:3
  • 10童乾纲,郑家平,叶强,张家兴,汝复明,奚顺法,吴访宏,王德贵,顾伟中.腔内热疗配合放化疗治疗中晚期食管癌[J].世界肿瘤杂志,2004,3(1):84-87. 被引量:19

共引文献13

同被引文献72

  • 1菅志远,李宜雄,李小刚,吕新生.X染色体连锁的凋亡抑制蛋白在胰腺癌组织及细胞中的表达及与化疗耐药的关系[J].中华消化杂志,2006,26(2):76-79. 被引量:9
  • 2冷卫东,王大章.放疗对舌鳞癌Tca8113细胞及其耐药细胞株耐药性的影响[J].实用口腔医学杂志,2006,22(5):615-619. 被引量:10
  • 3冯戈,王大章,陈槐卿,何嘉,冷卫东.人舌鳞癌Tca8113细胞荷瘤裸鼠体内诱导耐药性的实验研究[J].临床口腔医学杂志,2007,23(2):78-81. 被引量:2
  • 4Bmheim S, Bruland OS, Breistol K, et al. Human osteosarcoma xenografts and their sensitivity to chemotherapy. Pathol Oncol Res, 2004,10(3) :133-141.
  • 5Chang CC, Liang YC, Klutz A, et al. Reversal of multidrug resist-ance by two nordihydroguaiaretic acid derivatives, M4N and maltose- M3N, and their use in combination with doxorubicin or paclitaxel. Cancer Chemother Pharmacol, 2006,58 (5) :640-653.
  • 6Engel JB, Sehally AV, Halmos G, et al. Targeted therapy with a eytotoxic somatostatin analog, AN-238, inhibits growth of human experimental endometrial carcinomas expressing muhidrug resistance protein MDR-1. Cancer, 2005,104(6) :1312-1321.
  • 7Engel JB, Schally AV, Halmos G, et al. Experimental therapy of human endometrial cancers with a targeted cytotoxic bombesin analog AN-215 : low induction of muhidrug resistance proteins. Eur J Cancer, 2005,41 (12) : 1824-1830.
  • 8Miraeeo C, Maellaro E, Paeenti L, et al. Evaluation of MDRI, LRP, MRP, and topoisomerase Ⅱ alpha gene mRNA transcripts before and after interferon-alpha, and correlation with the mRNA expression level of the telomerase subunits hTERT and TEP1 in five unselected human melanoma cell lines. Int J Oncol, 2003,23 ( 1 ) :213- 220.
  • 9Wang B, Ngoi S, Wang J, et al. The promoter region of the MDR1 gene is largely invariant, but different single nucleotide polymorphism haplotypes affect MDR1 promoter activity differently in different cell lines. Mol Pharmacol, 2006,70( 1 ) :267-276.
  • 10Weerasinghe P, Hallock S, Tang SC, et al. Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Exp Toxicol Pathol, 2006,58( 1 ) :21-30.

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部